Literature DB >> 16752715

Carcinoma of the prostate: overview of the most common malignancy in men.

Culley C Carson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16752715

Source DB:  PubMed          Journal:  N C Med J        ISSN： 0029-2559


× No keyword cloud information.
  10 in total

1.  Basal epithelial stem cells are efficient targets for prostate cancer initiation.

Authors:  Devon A Lawson; Yang Zong; Sanaz Memarzadeh; Li Xin; Jiaoti Huang; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-25       Impact factor: 11.205

Review 2.  Follistatin as potential therapeutic target in prostate cancer.

Authors:  Maria Vittoria Sepporta; Francesca Maria Tumminello; Carla Flandina; Marilena Crescimanno; Marco Giammanco; Maurizio La Guardia; Danila di Majo; Gaetano Leto
Journal:  Target Oncol       Date:  2013-03-01       Impact factor: 4.493

3.  Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.

Authors:  Eun-Jin Yun; Jiancheng Zhou; Chun-Jung Lin; Elizabeth Hernandez; Ladan Fazli; Martin Gleave; Jer-Tsong Hsieh
Journal:  Clin Cancer Res       Date:  2015-10-21       Impact factor: 12.531

4.  Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation.

Authors:  Rita U Lukacs; Sanaz Memarzadeh; Hong Wu; Owen N Witte
Journal:  Cell Stem Cell       Date:  2010-12-03       Impact factor: 24.633

5.  Hypoxia-Responsive Mir-301a and Mir-301b Promote Radioresistance of Prostate Cancer Cells via Downregulating NDRG2.

Authors:  Wei Wang; Mingbo Liu; Yawei Guan; Qingwu Wu
Journal:  Med Sci Monit       Date:  2016-06-21

6.  Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling.

Authors:  Greg Shaw; David M Prowse
Journal:  Cancer Cell Int       Date:  2008-03-18       Impact factor: 5.722

7.  Berberine inhibited radioresistant effects and enhanced anti-tumor effects in the irradiated-human prostate cancer cells.

Authors:  Jung-Mu Hur; Dongho Kim
Journal:  Toxicol Res       Date:  2010-06

Review 8.  The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges.

Authors:  Eun-Jin Yun; U-Ging Lo; Jer-Tsong Hsieh
Journal:  Asian J Urol       Date:  2016-09-20

Review 9.  B lymphoma Moloney murine leukemia virus insertion region 1: An oncogenic mediator in prostate cancer.

Authors:  Qipeng Liu; Qiaqia Li; Sen Zhu; Yang Yi; Qi Cao
Journal:  Asian J Androl       Date:  2019 May-Jun       Impact factor: 3.285

10.  Exosomal TUBB3 mRNA expression of metastatic castration-resistant prostate cancer patients: Association with patient outcome under abiraterone.

Authors:  Sha Zhu; Yuchao Ni; Guangxi Sun; Zilin Wang; Junru Chen; Xingming Zhang; Jinge Zhao; Xudong Zhu; Jindong Dai; Zhenhua Liu; Jiayu Liang; Haoran Zhang; Yaowen Zhang; Pengfei Shen; Hao Zeng
Journal:  Cancer Med       Date:  2021-07-28       Impact factor: 4.452
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.